Buy Rating and New R
Buy Rating and New Report Issued for Plandai Biotechnology, Inc.
September 23, 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 23, 2013) - Stock Market Media Group, a research and content development investor relations firm, has released its 3rd Quarter report and issued a Speculative Buy...
Knowing Your Family History Is Good for Your Health
September 19, 2013 05:00 ET | Identigene
MISSION, KS--(Marketwired - Sep 19, 2013) - (Family Features) A number of celebrities have graced recent headlines by making some drastic decisions about their health, and in turn, raising...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces Commencement of Clinical Trials Using Phytofare Topical Product
September 05, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 5, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Orgenesis to Present at the 2013 Gateway Conference on September 10
September 04, 2013 17:15 ET | Orgenesis Inc.
SAN FRANCISCO, CA--(Marketwired - Sep 4, 2013) - Orgenesis, Inc. (OTCBB: ORGS), a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells...
Plandai Biotechnolog
Plandai Biotechnology, Inc.'s Phytofare Could Address Growing Diabetes Numbers
September 04, 2013 13:53 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) is already hard at work in Africa to develop a treatment for malaria, and it may just have a product in its...
Plandai Biotechnolog
Plandai Biotechnology, Inc. Announces Completion of Production Facility, Installation of Equipment to Commence
September 04, 2013 09:00 ET | Plandai Biotechnology, Inc.
SEATTLE, WA--(Marketwired - Sep 4, 2013) - Plandaí Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical,...
Nuvilex, Inc. Restru
Nuvilex, Inc. Restructures Corporate Operations to Reflect Biotechnology Focus
August 23, 2013 09:15 ET | Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Aug 23, 2013) - Nuvilex, Inc. (OTCQB: NVLX) (Company), an international biotechnology company and former provider of natural products, as well as cell and gene...
Nuvilex, Inc. Invest
Nuvilex, Inc. Investing Big in What Could Be Its Billion Dollar Future
August 20, 2013 08:30 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 20, 2013) - Nuvilex, Inc. (OTCQB: NVLX) just acquired oncology assets that make this small Silver Spring, Maryland, biotech worth more today than it was just a...
Nuvilex, Inc. to Con
Nuvilex, Inc. to Control 2 of the Big 3 Multi Billion Dollar Drug Markets With Technology
August 07, 2013 08:30 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Aug 7, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is methodically laying the foundation today for what should be a very busy and promising future tomorrow. After making a...
Nuvilex, Inc., Johns
Nuvilex, Inc., Johnson & Johnson, and Medtronic, Inc., All Developing Type of Artificial Pancreas for Diabetics
July 02, 2013 08:30 ET | Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 2, 2013) - While Medtronic, Inc. and Johnson & Johnson are developing devices that can essentially act as a type of "artificial pancreas," Nuvilex, Inc.'s...